Michigan Panel Votes 4-2 In Support Of Cannabis Use For Children With Autism, LARA Director Denies Petition.
Mike Zimmer, the Director of LARA in Michigan, has taken the futures of children and their families into his hands, only to crush them, insult them, and put all of their lives in danger. I was in attendance on July 31st 2015 at the last autism hearing in Lansing when the panel was finally given the chance to make an informed vote of 4-2 in favor of Autism being added to the list of qualifying conditions for medical marijuana.
I held our 4-year-old son Emery affectionately in my arms as I spoke in front of the panel of our experience over the last year and how it has changed us. We are able to give Emery cannabis because of his epilepsy diagnosis. I explained what it has done to reverse his autism impairment, to help him grow and to be happy, and for us to be able to live together in the same home. Before cannabis, we were going to have to live in separate homes on the same farmland together. Emery could not help but attack everyone around him constantly, including his younger siblings. Now, we happily spend entire days together and can hardly imagine the road we were headed down before Emery’s brain was allowed to work the way it is meant to because of cannabis.
We were at the hearing with other friends as well. These friends have been fighting this for over two years. They are parents, family, friends, attorneys, doctors, experts, and other activists. Parents with adult autistic children spoke to the panel as well. These parents have spent decades watching their children suffer as they refill endless bottles of dangerous pharmaceutical medications. They explained that from all of their research and everything they have seen, they believe that cannabis will work. They want to try it.
Parents like Dwight Zahringer have seen that other children using cannabis are not only experiencing changes in behavior and sleep patterns, but are also becoming verbal for the first time. Like every parent, these are things that he wants deeply for his own son, who is mostly non-verbal at the age of three. The original petitioner Lisa Smith’s son Noah, who has been non-verbal his whole life, has just recently started talking at the age of six because of cannabis. Parents caring for children with an autism diagnosis shouldn’t have to wait another day to try a proven safe and effective medicine that is non-toxic and has never caused a death. This is especially true when it’s helping so many people already.
Mike Zimmer denied the petition despite the panel’s recommendation to add it to the qualifying list of conditions.
The panel is specifically designated by LARA to make the decisions regarding new conditions that should qualify for protection under the MMMA. They reviewed over seventy-five peer-reviewed articles with over eight hundred pages of scientific information relating to the paediatric use of cannabis for autism. Parents should be able to choose this medicine for their autistic children. Adults who are suffering should be able to qualify as well. But instead of passing this decision through so that families can finally find relief, healing, and new positive experiences, Mike Zimmer denied it. From the decision:
“This lack of scientific evidence is concerning … the petition fails to acknowledge the direct impact on children… .”
And Lt. Governor Brian Calley, who has an autistic child of his own, weighed in by saying “there are neither sufficient studies nor scientific trials demonstrating its clinical impact to justify approval at this time.”
Maybe what these guys need is over eight hundred pages of information on the dangers of using anti-psychotics, anti-depressants, anti-insomnia, and anti-anxiety medications on children just to help them cope or to control dangerous behaviors.
Zimmer writes that children with autism “without associated seizure disorders” are already eligible under the language of the MMMA. He implies that if there are no seizures, then the autism is not severe, with no clear definition for what severe autism is.
Let’s help him with that: autism is a word with six letters. That’s it. But children with an autism diagnosis, whether it is considered severe or not, have to see doctors to get that diagnosis. And there are reasons for seeing the doctors. Parents can’t just walk into a dispensary and get an autism diagnosis and a medical card. Children with these conditions have a neurologist and sometimes many other doctors that they see regularly to monitor their growth, behaviors, and intelligence. It feels like what Mike Zimmer is really saying is that he doesn’t trust the many compassionate doctors, attorneys, parents, experts, social workers and other professionals who work in this field. These are the people who spend time with autistic children and their families.
They support this petition. Yet, he feels he has the right to make this decision for all of us.
He does not have that right.
He does not have the right to put a time limit on the lives of people or to force parents to separate siblings from each other when they can grow up together as friends, happily and peacefully. He doesn’t have the right to choose the number of children that are allowed to thrive and succeed in this world. In his Final Determination letter, he even makes it a point to rebut the claims that adding autism would cause a minimal increase in participation among minors.
This guy is the head of LARA, the agency that licenses these physicians, and he relies upon the argument that the doctors that we license can’t be trusted and will abuse the system. To follow his logic, his licensed physicians will treat autistic patients who they are not qualified to treat … The solution is that he can regulate this through the physicians and lay down rules and regulations. Instead he shuts it down.
None of this matters, of course. Every child with an autism diagnosis will benefit from using cannabis. This is clearly outlined in all of the peer-reviewed information that was included with the petition even aside from the hundreds, if not thousands, of miraculous stories from all across the country. These are stories of autism impairment being reversed, sometimes seemingly overnight, just from using low doses of cannabis oil or other forms of cannabis. Let’s make sure these people have all the information they need to make this right for us!
THIS IS A CALL FOR ACTION!
California and D.C parents can already treat their children with cannabis for autism. This fight has been going on in Michigan for long enough now that a lot of people far and away are paying attention. When autism is added to the list of qualifying conditions in Michigan, our children will literally become the long-term studies that Mike Zimmer and other opponents of the petition claim that we need to have first.
Please take a few minutes out of your day and call LARA and the Governor’s office, or send out some emails or faxes. It really does mean a lot to everyone who works hard on this. It could make a huge difference in the outcome and aftermath of Zimmer’s final determination letter, which is included in the article. If you have any creative ideas or information that you feel could help, please tell us about it. Some websites that you can contact are listed below. If you have a success story you want to share, feel free to share in the comments below as well. This might be a game to these politicians and profiteers, but these are our lives! We deserve to create them ourselves!
Here is the contact information for Mike Zimmer, Brian Calley, and the Governor’s Office. Please help these guys understand!
Brian Calley
https://www.facebook.com/briancalley
Mike Zimmer
Phone: (517) 373-3286
Email: zimmerm@michigan.gov
Licensing and Regulatory Affairs
P.O. Box 30004
Lansing, MI 48909
Phone: (517) 373-1820
Fax: (517) 373-2129
This is a link to “The Endocannabinoid System as it Relates to Autism” – Joe Stone; Christian Bogner, M.D. Its references list the peer-reviewed scientific articles relating to cannabis in the treatment of autism that were included in the petition to add autism to the list of qualifying conditions to use cannabis in Michigan:
A new study published in the Journal of Bone and Mineral Research has found that smoking marijuana may help to heal broken bones more quickly.
Researchers at Tel Aviv University found that rats with broken bones healed more quickly when given cannabinoid, or CBD, the non-psychotropic compound in weed, and THC.
The study, published in the Journal of Bone and Mineral Research on Thursday found that the bones not only healed quicker, but were also stronger and more resilient against a repeated fracture, meaning the bones treated with marijuana were much less likely to break again.
The scientists behind the research believe that this is due to a connection between cannabinoid receptors in the human body and the stimulation of bone growth.
Dr. Yankel Gabet of Tel Aviv’s Bone Research Laboratory presented findings that show that cannabidiol (CBD), a non-psychoactive chemical found in marijuana, may have therapeutic qualities in the mending of fractured bones. CBD can be separated from tetrahydrocannabinol (THC), the component of marijuana commonly attributed to cause the altered state produced by taking the substance.
Because of the ability of the chemical to able to have positive outcomes for the healing of broken bones, there will undoubtedly be a continued effort to prove the effectiveness of CBD. Medical marijuana has also been shown to be effective for a range of other ailments. One of the most recently discovered is a possible positive influence on Alzheimer’s disease. A study published in the Journal of Alzheimer’s Disease presented findings indicative of a use for the substance to treat the disease, previously reported Inquisitr.
State officials on Monday acknowledged they’d omitted hundreds of pages of medical studies from packets supplied to a state review panel slated to consider medical marijuana for treating autism according to the Detroit Free Press.
The panel will reconvene July 31 to reconsider autism, officials said.
“I became aware several weeks ago that we hadn’t received a huge number of documents, maybe six or eight hundred pages,” said David Brogren, 61, a retired insurance agent who treats his multiple sclerosis with medical marijuana.
Brogren notifed state officials of the omission two weeks ago and was assured that the materials would be added to panel members voting packets, he said. Yet, at Monday’s hearing in a state office building in Lansing, “I brought in this thick pile of documents that they still hadn’t given to us” — he got them from the petitioner’s lawyer — “and I tossed it on the table,” said Brogren, who moved recently from Bloomfield Hills to Mason, near Lansing.
Staffers of LARA — the Michigan Department of Licensing and Regulatory Affairs — called for a 15-minute recess, met with lawyers from the Michigan Attorney General’s Office, then offered to provide the missing studies if the panel postponed its hearing to July 31 at 1 p.m., panel member Robert Noiva of Rochester said.
Panel members voted 5-0 to postpone as “the only fair thing to do,” said Noiva, associate dean for medical education at Oakland University’s William Beaumont School of Medicine in Auburn Hills.
“Licensing and Regulatory Affairs provided the information we were supposed to provide and David Brogren wanted the department to provide the reference materials cited” in the petition, said LARA spokesman Michael Loepp. The Michigan Attorney General’s Office referred questions to LARA.
4/20/15
Most adults agree with legalizing medicinal marijuana, but they’re a lot more uneasy when it comes to its use for sick kids.
And most by far — 4 in 5 adults — say kids shouldn’t see adults using it.
That’s according to the latest University of Michigan C.S. Mott Children’s Hospital National Poll on Children’s Health, which routinely asks what’s on the minds of the nation’s moms and dads — from how they’re using social media to what they think of new laws and policies.
It’s not surprising that adults are hesitant when it comes to medical therapies that many believe are still unproven, said Dr. Matt Davis, director of the National Poll and professor of pediatrics and internal medicine at U-M Medical School.
“From my experience as a physician, they commonly mention the lack of testing for testing as a reason for their concern,” said Davis, who as a pediatrician at U-M is not allowed to prescribe marijuana for children.
Michigan is one of nearly two dozen states that permit medical marijuana, but it also has stricter rules when it comes to children using medical marijuana.
The Mott poll is the first to examine parents’ views about medical pot for adults compared to their view about its use for children. It drew from responses in November and December of 2,176 adults — both parents and non-parents.
Davis said responses about adult use of medical marijuana were similar to polls elsewhere, offering “reassurance” that it accurately reflects adults’ views about marijuana’s use for children too.
More specifically, the poll found:
■Nearly 2 in 3 parents say their state should allow medical marijuana for adults.
■Just more than 1 in 3 say it should be allowed for children.
■Four in 5 people say adults shouldn’t be allowed to use medical marijuana in front of children
■1 in 10 said they either have a medical marijuana card or know someone who does.
Some in the audience, including parents of autistic children, labeled the omission an intentional obstruction by the Michigan Attorney General’s Office, headed by Bill Schuette, a strong opponent of medical marijuana. Schuette’s staff lawyers initially blocked the autism petition, first filed in May 2014, in a lengthy court fight before dropping opposition in April, said Michael Komorn, a Southfield attorney who successfully argued the case in Ingham County Circuit Court.
Over 100 Scientific Studies Agree Cannabis Annihilates Cancer
An interesting article from the website WakeUpWorld.com. A lot of links to government and other studies. Lots of scientific research stuff…Take a look.
Note: There is so much information here and there are a lot of links to many informative sites. Click here to open in a new page so you don’t lose KomornLaw.com site…or just add us to your favorites.
Considering that up until about 85 years ago, cannabis oil was used around the world to treat a variety of diseases, including cancer, it is not surprising that the phasing out of cannabis to treat illness coincided with the rise of pharmaceutical companies.
Rick Simpson, a medical marijuana activist, is on a crusade to help others heal. He regards cannabis as the most medicinally active plant on the face of the earth, and shared this apparent miracle with others — completely free of charge. He now has thousands of testimonials from those who were healed from ‘incurable’ disease to back up his claims ~ that cannabis annihilates cancer.
For the naysayers out there who are still not convinced about the effectiveness of cannabis for curing cancer, the astounding healing attributes of the plant are well documented by a wealth of peer-reviewed studies.
Traditional medicinal plant backed by modern medicine
Breast cancer
A study in Molecular Cancer Therapeutics explored the relationship between the use of cannabidiol (CBD) and the subsequent down regulation of breast cancer tumor aggressiveness. The researchers concluded that CBD represents the first nontoxic agent to decrease the aggressiveness of metastic breast cancer cells in vivo.
Furthermore, the journal PLoS One reports further evidence of how cannabinoids modulate breast cancer tumor growth and metastasis by inhibiting specific receptors.
“Studies on epithelial cells have shown that cannabinoids exert antiproliferative, antimetastatic and apoptotic effects as well as reducing cytokine release and promoting wound healing. In vivo, cannabinoids – via direct or indirect activation of CB(1) and/or CB(2) receptors – exert protective effects in well-established models of intestinal inflammation and colon cancer.”
The team concluded that the administration of cannabinoids “may be a promising strategy to counteract intestinal inflammation and colon cancer.”
Cannabis was shown to induce cytotoxicity in leukemia cell lines, according the the journal Blood:
“We have shown that THC is a potent inducer of apoptosis, even at 1 x IC(50) (inhibitory concentration 50%) concentrations and as early as 6 hours after exposure to the drug. These effects were seen in leukemic cell lines (CEM, HEL-92, and HL60) as well as in peripheral blood mononuclear cells.”
It also did not appear that the cannabis was simply aiding other chemo drugs — it was independently bringing about results with the active compound THC responsible for cancer cell death in vitro.
Likewise, a study in the Molecular Pharmacology Journal found that non psychoactive cannabidiol dramatically induced apoptosis (cell death) in leukemia cells. “Together, the results from this study reveal that cannabidiol, acting through CB2 and regulation of Nox4 and p22(phox) expression, may be a novel and highly selective treatment for leukemia.”
Research published in the paper Prostaglandins, Leukotrienes and Essential Fatty Acids found that cannabinoid compounds play a vital role in modulating the immune system to improve the outcome of a cancer diagnosis. In short, the team believes “[t]he experimental evidence reviewed in this article argues in favor of the therapeutic potential of these compounds in immune disorders and cancer.”
Moreover, the study Cannabinoids and the immune system confirms that cannabimimetic agents have substantial effects on natural killer cells, thereby providing therapeutic usefulness in reducing tumor growth and the induction of apoptosis. Therefore, cannabis demonstrates a “subtle but significant role in the regulation of immunity and that this role can eventually be exploited in the management of human disease.”
Cervical cancer
Uterine cervical cancer cells are significantly influenced by cannabis as well. Published in Gynecologic Oncology, the research team discovered that the compound induced apoptosis in cervical carcinoma (CxCa) cell lines.
Melanoma
The most deadly form of skin cancer, melanoma has relatively few options of treatment beyond prevention and early detection. With this in mind, the findings of the study Cannabinoid receptors as novel targets for the treatment of melanoma are of particular note. In animal tests, cannabinoids encouraged cancer cell death, while decreasing growth, proliferation and metastasis of melanoma cells.
“Local administration of [cannabinoids] induced a considerable growth inhibition of malignant tumors generated by inoculation of epidermal tumor cells into nude mice. Cannabinoid-treated tumors showed an increased number of apoptotic cells. This was accompanied by impairment of tumor vascularization, as determined by altered blood vessel morphology and decreased expression of proangiogenic factors (VEGF, placental growth factor, and angiopoietin 2). … These results support a new therapeutic approach for the treatment of skin tumors.”
These are just a few examples — among hundreds — that demonstrate the effectiveness of cannabis in eradicating cancer without adverse side-effects. Additionally, the following documentary explores the history and modern uses of cannabis to heal serious diseases such as cancer, AIDS, Crohn’s disease & more:
Medical Cannabis and Its Impact on Human Health: a Cannabis Documentary
Scientific Studies from the National Institute of Health
If you’re still in doubt regarding the effectiveness of cannabis for healing cancer, have a look at these 100+ scientific studies from the National Institute of Health:
Just had to place this article as it was without blog banter. Go ahead and read it.
BY PAUL ARMENTANO · MON MAR 02, 2015
Allegations from anti-pot proponents that cannabis use by adults causes serious harms are unwarranted and unproven. So says one of the nation’s leading marijuana researchers. Speaking recently to the American Association for the Advancement of Science (AAAS), Dr. Igor Grant acknowledged, “There is no evidence for long-term damaging effects in adults.” He ought to know. Over his professional tenure, Grant has authored several peer-review journal articles specific to the health effects of cannabis, including a 2003 report which concluded that the long-term heavy use of pot was not associated with the “substantial, systematic, and detrimental effect of cannabis use on neuropsychological performance.” Grant also served as the director of the University of California Center for Medicinal Cannabis Research, during which time he oversaw the completion of a number of FDA-approved clinical trials assessing the safety and efficacy of whole-smoked marijuana. In 2012, he co-authored a summary of these trials for the scientific journal Open Neurology.
“Based on evidence currently available the Schedule I classification is not tenable; it is not accurate that cannabis has no medical value, or that information on safety is lacking,” the article concluded. Speaking at this year’s AAAS meeting, Grant said that smoking cannabis long-term is associated with bronchitis. But he cautioned that purported links between cannabis and the onset of psychiatric disorders like schizophrenia have yet to be established. He also warned that allegations that cannabis harms the brain “are very weak at the moment.” Grant further acknowledged that the present Schedule I classification of the plant is inappropriate and severely hampers investigators from studying its effects.
“In the U.S. there are certainly a number of hurdles and processes one has to go through, and I think this does inhibit ordinary investigators who don’t have the means or the knowledge or the staying power to get through the system,” he said. On February 11, a federal judge for the Ninth Circuit heard closing arguments in a motion challenging the constitutionality of marijuana’s Schedule I classification. The case marks the first time since 1973 that a federal judge has weighed evidence in regard to whether there exists a “rational basis” for the government to maintain the plant’s prohibitive status The judge is anticipated to rule on the matter by mid-March.
A study from The Journal of Neuroscience dated January 28, 2015 was recently released with results from research on brain morphology of daily adult and adolescent users of marijuana.
Here are a few quotes from the study…
“The United States has seen changing trends concerning the acceptance of marijuana. As of 2013, 20 states had either decriminalized marijuana or legalized medical use. Colorado, Washington, Oregon, and Alaska have now legalized its recreational use. Concurrently, the popular press has shown significant interest in scientific studies on the effects of marijuana use.”
“Recent research has suggested that marijuana use is associated with volumetric and shape differences in subcortical structures, including the nucleus accumbens and amygdala, in a dose-dependent fashion. Replication of such results in well controlled studies is essential to clarify the effects of marijuana. To that end, this retrospective study examined brain morphology in a sample of adult daily marijuana users (n_29) versus nonusers (n_29) and a sample of adolescent daily users (n_50) versus nonusers (n_50).”
“No statistically significant differences were found between daily users and nonusers on volume or shape in the regions of interest. Effect sizes suggest that the failure to find differences was not due to a lack of statistical power, but rather was due to the lack of.”
“In sum, the results indicate that, when carefully controlling for alcohol use, gender, age, and other variables, there is no association between marijuana use and standard volumetric or shape measurements of subcortical structures.”
There is so much more in depth scientific data and information in this study that can be reviewed. If you are interested take a look.
Study from The Journal of Neuroscience- January 28, 2015
Michael Komorn is recognized as a leading expert on the Michigan Medical Marihuana Act. He is the President of the Michigan Medical Marijuana Association (MMMA), a nonprofit patient advocacy group with over 26,000 members, which advocates for medical marijuana patients, and caregiver rights. Michael is also the host of Planet Green Trees Radio, a marijuana reform based show, which is broadcast every Thursday night 8-10 pm EST. Follow Komorn on Twitter.
